Increased expression of FOXM1 is observed in a variety of human cancers, such as ovarian cancer, breast cancer, prostate cancer, hepatoma, angiosarcoma, colorectal cancer, melanoma, lung cancer, and gastric cancer [13–21], which is consistent with the results obtained from the TCGA database (Fig. 2). This evidence concerns the gene FOXM1 and ovarian carcinoma.